Sandbox:ap: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(4 intermediate revisions by 2 users not shown)
Line 15: Line 15:
{{familytree/end}}
{{familytree/end}}


== Differential diagnosis ==
=Codes=
{|
<div style="text-align: center;">'''Corrected total calcium = measured total calcium + 0.8 (4.0 − serum albumin)''' </div>
! colspan="4" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Hypoparathyroidism}}
 
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Inheritance}}
 
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Gene mutation}}
<div style="width: 70%;">
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Clinical features}}
 
|-
<br style="clear:left" />
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[Autoimmune]]'''
 
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Autoimmune polyglandular hypoparathyroidism'''
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[Autoimmune polyendocrine syndrome type 1]]'''<ref name="pmid2348835">{{cite journal |vauthors=Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J |title=Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients |journal=N. Engl. J. Med. |volume=322 |issue=26 |pages=1829–36 |year=1990 |pmid=2348835 |doi=10.1056/NEJM199006283222601 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mutation in AIRE gene
| style="padding: 5px 5px; background: #F5F5F5;" |
*Also known as [[Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome|autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy]] ([[APECED syndrome|APECED]]).
*Presents with a variable combination of:
**Failure of the [[Parathyroid gland|parathyroid glands]], [[adrenal cortex]], [[gonads]], [[pancreatic beta cells]], [[gastric parietal cells]], [[thyroid gland]], and [[hepatitis]].
**Chronic [[mucocutaneous]] [[candidiasis]]
**[[Dystrophy]] of [[dental enamel]] and [[nails]], [[alopecia]], [[vitiligo]], and keratopathy.
|-
| colspan="2" rowspan="7" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Isolated
| colspan="2" rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Familial Isolated hypoparathyroidism
| rowspan="2" style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |PTH gene<ref name="pmid2212001">{{cite journal |vauthors=Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM |title=Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism |journal=J. Clin. Invest. |volume=86 |issue=4 |pages=1084–7 |year=1990 |pmid=2212001 |pmc=296835 |doi=10.1172/JCI114811 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**[[Carpopedal spasm|Carpopedal spasms]].
**Circumoral [[numbness]].
|-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Glial cells missing [[GCM2]] gene<ref name="pmid18712808">{{cite journal |vauthors=Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN |title=Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism |journal=Hum. Mutat. |volume=30 |issue=1 |pages=85–92 |year=2009 |pmid=18712808 |doi=10.1002/humu.20827 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**[[Carpopedal spasm|Carpopedal spasms]].
**Circumoral [[numbness]].
*[[Dominant negative mutation]].
|-
| rowspan="2" style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |PTH gene<ref name="pmid10523031">{{cite journal |vauthors=Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S |title=A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism |journal=J. Clin. Endocrinol. Metab. |volume=84 |issue=10 |pages=3792–6 |year=1999 |pmid=10523031 |doi=10.1210/jcem.84.10.6070 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**[[Carpopedal spasm|Carpopedal spasms]].
**Circumoral [[numbness]].
|-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Glial cells missing 2 ([[GCM2]]) gene<ref name="pmid18712808">{{cite journal |vauthors=Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN |title=Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism |journal=Hum. Mutat. |volume=30 |issue=1 |pages=85–92 |year=2009 |pmid=18712808 |doi=10.1002/humu.20827 |url=}}</ref><ref name="pmid11602629">{{cite journal |vauthors=Ding C, Buckingham B, Levine MA |title=Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB |journal=J. Clin. Invest. |volume=108 |issue=8 |pages=1215–20 |year=2001 |pmid=11602629 |pmc=209530 |doi=10.1172/JCI13180 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**[[Carpopedal spasm|Carpopedal spasms]].
**Circumoral [[numbness]].
|-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[X-linked]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[FHL1 (gene)|FHL1]] gene (exon 4, c.C283T, p.R95W) on chromosome locus Xq26-q27<ref name="pmid28444561">{{cite journal |vauthors=Pillar N, Pleniceanu O, Fang M, Ziv L, Lahav E, Botchan S, Cheng L, Dekel B, Shomron N |title=A rare variant in the FHL1 gene associated with X-linked recessive hypoparathyroidism |journal=Hum. Genet. |volume=136 |issue=7 |pages=835–845 |year=2017 |pmid=28444561 |pmc=5487855 |doi=10.1007/s00439-017-1804-9 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**[[Carpopedal spasm|Carpopedal spasms]].
**Circumoral [[numbness]].
|-
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypercalcemia<ref name="pmid278036722">{{cite journal |vauthors=Roszko KL, Bi RD, Mannstadt M |title=Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2 |journal=Front Physiol |volume=7 |issue= |pages=458 |year=2016 |pmid=27803672 |pmc=5067375 |doi=10.3389/fphys.2016.00458 |url=}}</ref>
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypocalcemia type 1
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Calcium-sensing receptor]] [[gene mutation]]
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Calcium-sensing receptor]] gene activating mutation.
*'''Most common genetic form''' of hypoparathyroidism.
*Also known as familial hypercalciuric hypocalcemia.
*The activating mutation results in gain in function.
*[[Calcium-sensing receptor]] gene activating mutation can also cause mild [[Bartter syndrome]] type 5. This mutation cause the inhibition of apical potassium channel in the thick ascending limb of the [[loop of Henle]] in the [[kidney]].<ref name="pmid17048213">{{cite journal |vauthors=Vezzoli G, Arcidiacono T, Paloschi V, Terranegra A, Biasion R, Weber G, Mora S, Syren ML, Coviello D, Cusi D, Bianchi G, Soldati L |title=Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome |journal=J. Nephrol. |volume=19 |issue=4 |pages=525–8 |year=2006 |pmid=17048213 |doi= |url=}}</ref><ref name="pmid25932037">{{cite journal |vauthors=Choi KH, Shin CH, Yang SW, Cheong HI |title=Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C |journal=Korean J Pediatr |volume=58 |issue=4 |pages=148–53 |year=2015 |pmid=25932037 |pmc=4414630 |doi=10.3345/kjp.2015.58.4.148 |url=}}</ref>
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypocalcemia type 2
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |G protein G11 ([[GNA11]]) mutation
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**[[Carpopedal spasm|Carpopedal spasms]].
**Circumoral [[numbness]].
|-
| colspan="2" rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Congenital multisystem syndromes
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[DiGeorge syndrome]]'''<ref name="pmid21049214">{{cite journal |vauthors=Fomin AB, Pastorino AC, Kim CA, Pereira CA, Carneiro-Sampaio M, Abe-Jacob CM |title=DiGeorge Syndrome: a not so rare disease |journal=Clinics (Sao Paulo) |volume=65 |issue=9 |pages=865–9 |year=2010 |pmid=21049214 |pmc=2954737 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[22q11.2 deletion syndrome|22q11.2 deletion]].
| style="padding: 5px 5px; background: #F5F5F5;" |
* Presents with [[thymus]] [[dysfunction]], [[cardiac]] defects, [[immunodeficiency]], [[hypocalcemia]], and other clinical problems.
*Also known as [[22q11.2DS]], [[CATCH 22 syndrome]], [[Cayler cardiofacial syndrome]], [[conotruncal anomaly face syndrome]] ([[CTAF]]), [[deletion 22q11.2 syndrome]], [[Sedlackova syndrome]], [[Shprintzen syndrome]], VCFS, [[velocardiofacial syndrome]], and velo-cardio-facial syndrome.
*[[CATCH 22 syndrome|CATCH 22]] stands for [[cardiac]] defects, abnormal facies, [[thymic]] [[aplasia]], [[cleft palate]], and [[hypocalcemia]] with [[22q11.2 deletion syndrome|22q11.2 deletion]].
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[CHARGE syndrome]]'''<ref name="pmid21995344">{{cite journal |vauthors=Jain S, Kim HG, Lacbawan F, Meliciani I, Wenzel W, Kurth I, Sharma J, Schoeneman M, Ten S, Layman LC, Jacobson-Dickman E |title=Unique phenotype in a patient with CHARGE syndrome |journal=Int J Pediatr Endocrinol |volume=2011 |issue= |pages=11 |year=2011 |pmid=21995344 |pmc=3216247 |doi=10.1186/1687-9856-2011-11 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |CHD7 G744S [[missense mutation]]
| style="padding: 5px 5px; background: #F5F5F5;" |
* Presents with [[coloboma]], [[heart]] defects, [[Choanal atresia|atresia choanae]], retarded growth and development, [[Genitourinary pathology|genitourinary abnormalities]], and [[ear]] anomalies and/or [[deafness]].
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Kenny-Caffey syndrome type 1'''<ref name="pmid23087875">{{cite journal |vauthors=Metwalley KA, Farghaly HS |title=Kenny-Caffey syndrome type 1 in an Egyptian girl |journal=Indian J Endocrinol Metab |volume=16 |issue=5 |pages=827–9 |year=2012 |pmid=23087875 |pmc=3475915 |doi=10.4103/2230-8210.100645 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Deletion of the [[TBCE]] gene
| style="padding: 5px 5px; background: #F5F5F5;" |
* Presents with [[hypoparathyroidism]] due to absent [[Parathyroid gland|parathyroid tissue]], growth retardation, medullary stenosis of tubular bones.
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Kenny-Caffey syndrome type 2'''<ref name="pmid23996431">{{cite journal |vauthors=Isojima T, Doi K, Mitsui J, Oda Y, Tokuhiro E, Yasoda A, Yorifuji T, Horikawa R, Yoshimura J, Ishiura H, Morishita S, Tsuji S, Kitanaka S |title=A recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2 |journal=J. Bone Miner. Res. |volume=29 |issue=4 |pages=992–8 |year=2014 |pmid=23996431 |doi=10.1002/jbmr.2091 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mutation of “family with sequence similarity 111, member A″ (FAM111A) gene located on chromosome locus 11q12.1
| style="padding: 5px 5px; background: #F5F5F5;" |
* Patients with Kenny-Caffey sundrome type 2 have same clinical features as Kenny-Caffey syndrome type 1 except for [[mental retardation]].
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Sanjad-Sakati syndrome'''<ref name="pmid22043344">{{cite journal |vauthors=Rafique B, Al-Yaarubi S |title=Sanjad-Sakati Syndrome in Omani children |journal=Oman Med J |volume=25 |issue=3 |pages=227–9 |year=2010 |pmid=22043344 |pmc=3191633 |doi=10.5001/omj.2010.63 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mutation in [[TBCE]] gene.
| style="padding: 5px 5px; background: #F5F5F5;" |
* Sanjad-Sakati syndrome in exclusively found in arabian descent population.
* Presents with hypoparathyroidism, [[intellectual disability]], [[Dysmorphic feature|dysmorphism]].
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[Barakat syndrome]]'''<ref name="pmid11389161">{{cite journal |vauthors=Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y, Hasegawa Y, Ogata T |title=GATA3 abnormalities and the phenotypic spectrum of HDR syndrome |journal=J. Med. Genet. |volume=38 |issue=6 |pages=374–80 |year=2001 |pmid=11389161 |pmc=1734904 |doi= |url=}}</ref><ref name="pmid10935639">{{cite journal |vauthors=Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de Ven W, Thakker RV, Devriendt K |title=GATA3 haplo-insufficiency causes human HDR syndrome |journal=Nature |volume=406 |issue=6794 |pages=419–22 |year=2000 |pmid=10935639 |doi=10.1038/35019088 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Mutation|Mutations]] in the [[GATA3]] gene
| style="padding: 5px 5px; background: #F5F5F5;" |
*Also known as hypoparathyroidism, [[deafness]], and renal dysplasia (HDR) syndrome.
*Presents with primary hypoparathyroidism, nerve [[deafness]], steroid-resistant [[nephrosis]].
|-
| rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Metabolic diseases'''
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Mitochondiral polyneuropathies'''<ref name="pmid27716753">{{cite journal |vauthors=Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S |title=Mitochondrial disease and endocrine dysfunction |journal=Nat Rev Endocrinol |volume=13 |issue=2 |pages=92–104 |year=2017 |pmid=27716753 |doi=10.1038/nrendo.2016.151 |url=}}</ref>
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Kearns–Sayre syndrome'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Mitochondrial inheritence
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | mtDNA deletion
| style="padding: 5px 5px; background: #F5F5F5;" |
*Progressive external [[ophthalmoplegia]]
*[[Retinitis pigmentosa]]
*[[Cardiomyopathy]]
*[[Heart block]]
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Maternally inherited diabetes and deafness (MIDD)'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Mitochondrial inheritence
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | MT‑TL1 defect
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Diabetes mellitus]]
*[[Deafness]]
|-
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Mitochondrial enzyme deficiencies'''
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Mitochondrial trifunctional protein deficiency (MTP deficiency)'''<ref name="pmid16523289">{{cite journal |vauthors=Labarthe F, Benoist JF, Brivet M, Vianey-Saban C, Despert F, de Baulny HO |title=Partial hypoparathyroidism associated with mitochondrial trifunctional protein deficiency |journal=Eur. J. Pediatr. |volume=165 |issue=6 |pages=389–91 |year=2006 |pmid=16523289 |doi=10.1007/s00431-005-0052-5 |url=}}</ref><ref name="urlmitochondrial trifunctional protein deficiency - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/mitochondrial-trifunctional-protein-deficiency |title=mitochondrial trifunctional protein deficiency - Genetics Home Reference |format= |work= |accessdate=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | [[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | HADHA or HADHB gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of mitochondrial trifunctional protein deficiency occurring '''during''' [[Infancy|'''infancy''']] include:
**[[Feeding difficulties]]
**[[Lethargy]]
**[[Hypoglycemia]]
**[[Hypotonia]]
**[[Liver disease|Liver problems]]
*[[Infant|Infants]] with mitochondrial trifunctional protein deficiency are also at '''increased risk''' for:
**Serious [[heart]] problems
**[[Breathing difficulties]]
**[[Coma]]
**[[Sudden death]]
*Clinical features of mitochondrial trifunctional protein deficiency occurring '''after [[infancy]]''' include:
**[[Hypotonia]]
**[[Muscle pain]]
**Breakdown of muscle tissue
**[[Peripheral neuropathy]]
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency]] ([[LCHAD deficiency]])'''<ref name="pmid9403664">{{cite journal |vauthors=Tyni T, Rapola J, Palotie A, Pihko H |title=Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation |journal=J. Pediatr. |volume=131 |issue=5 |pages=766–8 |year=1997 |pmid=9403664 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |G1528C gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of [[LCHAD deficiency]] include:
**[[Hypoglycemia]]
**[[Hepatopathy]]
**[[Hypotonia]]
**[[Cardiomyopathy]]
**[[Retinopathy]]
|-
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Heavy metal storage disorders'''
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Hemochromatosis'''<ref name="pmid24741460">{{cite journal |vauthors=Jeong HK, An JH, Kim HS, Cho EA, Han MG, Moon JS, Kim HK, Kang HC |title=Hypoparathyroidism and subclinical hypothyroidism with secondary hemochromatosis |journal=Endocrinol Metab (Seoul) |volume=29 |issue=1 |pages=91–5 |year=2014 |pmid=24741460 |pmc=3970271 |doi=10.3803/EnM.2014.29.1.91 |url=}}</ref><ref name="urlhereditary hemochromatosis - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/hereditary-hemochromatosis |title=hereditary hemochromatosis - Genetics Home Reference |format= |work= |accessdate=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HFE]] [[gene mutation]]
| style="padding: 5px 5px; background: #F5F5F5;" |
*Early symptoms of [[hereditary hemochromatosis]] are nonspecific and may include:
**[[Fatigue]]
**[[Arthralgia|Joint pain]]
**[[Abdominal pain]]
**[[Decreased libido]]
*Late stage clinical features may include:
**[[Arthritis]]
**[[Liver disease]]
**[[Diabetes]]
**[[Heart]] abnormalities
**[[Skin discoloration]]
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Wilson's disease'''<ref name="pmid6888480">{{cite journal |vauthors=Carpenter TO, Carnes DL, Anast CS |title=Hypoparathyroidism in Wilson's disease |journal=N. Engl. J. Med. |volume=309 |issue=15 |pages=873–7 |year=1983 |pmid=6888480 |doi=10.1056/NEJM198310133091501 |url=}}</ref><ref name="urlWilson disease - Genetics Home Reference">{{cite web |url=https://ghr.nlm.nih.gov/condition/wilson-disease#definition |title=Wilson disease - Genetics Home Reference |format= |work= |accessdate=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | [[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ATP7B gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of [[Wilson's disease]] include:
**'''Initial feature'''
***'''Children and young adults:''' [[Liver disease]]
***'''Adults:''' [[Nervous system disease|Nervous system disorders]] and [[Psychiatric Disorders|psychiatric disorders]]
*Other clinical features include:
**[[Clumsiness]]
**[[Tremors]]
**[[Difficulty walking]]
**[[Speech problems]]
**Impaired thinking ability
**[[Depression]]
**[[Anxiety]]
**[[Mood swings]]
|}
==References==
==References==

Latest revision as of 15:49, 5 March 2018

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypercalcemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Related to Parathyroid gland
 
 
 
 
 
 
 
 
 
 
 
Unrelated to parathyroid gland
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary hyperparathyroidism
 
 
Secondary hyperparathyroidism
 
 
Tertiary hyperparathyroidism
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Typical primary hyperparathyroidism
 
Familial hypocalciuric hypercalcemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Malignancy
 
 
 
 
 
Medication induced
 
 
 
Nutritional
 
 
 
 
Granulomatous disease
 
 
Surgical
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Para-neoplastic syndrome: Parathyroid hormone related peptide
 
Metaplasia: Hypercalcemia due to bone destruction
 
Thiazide diuretics
 
Lithium
 
Milk alkali syndrome
 
Vitamin D toxicity
 
Sarcoidosis
 
 
Immobilization
 

Codes

Corrected total calcium = measured total calcium + 0.8 (4.0 − serum albumin)



References

Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:ap&oldid=1451595"